Yingda Xu
Impact in
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Protein purification and stability 18
- Viral Infectious Diseases and Gene Expression in Insects 7
-
- Monoclonal and Polyclonal Antibodies Research 20
- Co-authors
- Yingming Zhao (6 shared papers)Sung Chan Kim (4 shared papers)Robert W. Sprung (3 shared papers)Haydn L. Ball (1 shared paper)Yoonjung Kho (1 shared paper)Nick V. Grishin (1 shared paper)Yue Chen (1 shared paper)Hao Xiao (1 shared paper)
- Journals
- mAbs (10 papers)Journal of Proteome Research (2 papers)Analytical Chemistry (2 papers)SLAS DISCOVERY (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesChinaIndia
In The Last Decade
Yingda Xu
39 papers receiving 3.2k citations
Yingda Xu's Hit Papers
Peers
Comparison fields: 5 of 117
- Geriatrics and Gerontology 416
- Radiology, Nuclear Medicine and Imaging 1.2k
- Molecular Biology 2.5k
- Spectroscopy 394
- Oncology 503
Countries citing papers authored by Yingda Xu
This map shows the geographic impact of Yingda Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingda Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingda Xu more than expected).
Fields of papers citing papers by Yingda Xu
This network shows the impact of papers produced by Yingda Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingda Xu. The network helps show where Yingda Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yingda Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Substrate and Functional Diversity of Lysine Acetylation Revealed by a Proteomics Survey Hit paper breakdown → | 2006 | 1233 |
| 2 | Biophysical properties of the clinical-stage antibody landscape Hit paper breakdown → | 2017 | 412 |
| 3 | 2018 | 185 | |
| 4 | 2007 | 125 | |
| 5 | 2013 | 119 | |
| 6 | 2013 | 103 | |
| 7 | 2006 | 102 | |
| 8 | 2018 | 97 | |
| 9 | 2006 | 90 | |
| 10 | 2003 | 81 | |
| 11 | 2019 | 68 | |
| 12 | 2015 | 66 | |
| 13 | 2010 | 65 | |
| 14 | 2002 | 63 | |
| 15 | 2013 | 60 | |
| 16 | 2017 | 52 | |
| 17 | 2015 | 48 | |
| 18 | 2017 | 43 | |
| 19 | 2013 | 43 | |
| 20 | 2016 | 39 |
About Yingda Xu
Yingda Xu is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Spectroscopy, Immunology and Cardiology and Cardiovascular Medicine, having authored 40 papers that have together received 3.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (20 papers), Protein purification and stability (18 papers), Viral Infectious Diseases and Gene Expression in Insects (7 papers), Mass Spectrometry Techniques and Applications (5 papers), Cerebrovascular and Carotid Artery Diseases (4 papers), Acute Ischemic Stroke Management (3 papers), Blood Pressure and Hypertension Studies (3 papers) and Advanced Proteomics Techniques and Applications (3 papers). The work is most often cited by research in Geriatrics and Gerontology (416 citations), Radiology, Nuclear Medicine and Imaging (1.2k citations), Molecular Biology (2.5k citations), Spectroscopy (394 citations) and Oncology (503 citations). Yingda Xu has collaborated with scholars based in United States, China and India. Frequent co-authors include Yingming Zhao, Sung Chan Kim, Robert W. Sprung, Haydn L. Ball, Yoonjung Kho, Nick V. Grishin, Yue Chen, Hao Xiao, Jimin Pei and Lin Xiao. Their work appears in journals such as mAbs, Journal of Proteome Research, Analytical Chemistry, SLAS DISCOVERY and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.